37 related articles for article (PubMed ID: 8870988)
21. Synergistic vascular toxicity and fatty acid anilides in the toxic oil syndrome.
Boor PJ; Khan MF; Kaphalia BS; Jerrells TR; Ansari GA
J Am Coll Cardiol; 1991 Dec; 18(7):1824-8. PubMed ID: 1960335
[TBL] [Abstract][Full Text] [Related]
22. Toxic oil syndrome: the perspective after 20 years.
Posada de la Paz M; Philen RM; Borda AI
Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
[TBL] [Abstract][Full Text] [Related]
23. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Kaufman LD; Krupp LB
Curr Opin Rheumatol; 1995 Nov; 7(6):560-7. PubMed ID: 8579979
[TBL] [Abstract][Full Text] [Related]
24. The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism.
Aldridge WN
Toxicol Lett; 1992 Dec; 64-65 Spec No():59-70. PubMed ID: 1471212
[TBL] [Abstract][Full Text] [Related]
25. Immunological aspects of the toxic oil syndrome.
Lahoz C; del Pozo V; Gallardo S; Cárdaba B; Jurado A; Cortegano I; del Amo A; Arrieta I; Palomino P
Arch Toxicol Suppl; 1997; 19():65-73. PubMed ID: 9079195
[No Abstract] [Full Text] [Related]
26. Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds.
Kammüller ME; Bloksma N; Seinen W
J Toxicol Clin Toxicol; 1988; 26(3-4):157-74. PubMed ID: 3047417
[TBL] [Abstract][Full Text] [Related]
27. The toxic oil syndrome: an example of an exogenously induced autoimmune reaction. Toxic oil syndrome.
Bell SA
Mol Biol Rep; 1996; 23(3-4):261-3. PubMed ID: 9112238
[TBL] [Abstract][Full Text] [Related]
28. The toxic oil syndrome.
James TN
Clin Cardiol; 1994 Sep; 17(9):463-70. PubMed ID: 8001309
[TBL] [Abstract][Full Text] [Related]
29. A multisystemic disease caused by adulterated rapeseed oil.
Pascual-Castroviejo I
Brain Dev; 1988; 10(2):84-7. PubMed ID: 3291629
[TBL] [Abstract][Full Text] [Related]
30. [15 years of research on toxic oil syndrome].
Pestaña A
Med Clin (Barc); 1997 Mar; 108(11):421-3. PubMed ID: 9213640
[No Abstract] [Full Text] [Related]
31. A search for an animal model of the Spanish toxic oil syndrome.
Hard GC
Food Chem Toxicol; 2002 Nov; 40(11):1551-67. PubMed ID: 12176082
[TBL] [Abstract][Full Text] [Related]
32. Products of aniline and triglycerides in oil samples associated with the toxic oil syndrome.
Schurz HH; Hill RH; Posada de la Paz M; Philen RM; Borda IA; Bailey SL; Needham LL
Chem Res Toxicol; 1996 Sep; 9(6):1001-6. PubMed ID: 8870988
[TBL] [Abstract][Full Text] [Related]
33. [Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
Maitani T; Saitoh H
Shokuhin Eiseigaku Zasshi; 2009 Dec; 50(6):279-91. PubMed ID: 20065617
[No Abstract] [Full Text] [Related]
34. Contribution of denaturing and deodorization processes of oils to toxic oil syndrome.
Ruiz-Méndez MV
Chem Biol Interact; 2011 Jun; 192(1-2):142-4. PubMed ID: 21238434
[TBL] [Abstract][Full Text] [Related]
35. The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge.
Gelpí E; de la Paz MP; Terracini B; Abaitua I; de la Cámara AG; Kilbourne EM; Lahoz C; Nemery B; Philen RM; Soldevilla L; Tarkowski S;
Environ Health Perspect; 2002 May; 110(5):457-64. PubMed ID: 12003748
[TBL] [Abstract][Full Text] [Related]
36. The toxic oil syndrome: 20 years on.
Diggle GE
Int J Clin Pract; 2001; 55(6):371-5. PubMed ID: 11501225
[TBL] [Abstract][Full Text] [Related]
37. The toxic oil syndrome: a perspective on immunotoxicological mechanisms.
Yoshida SH; German JB; Fletcher MP; Gershwin ME
Regul Toxicol Pharmacol; 1994 Feb; 19(1):60-79. PubMed ID: 8159816
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
